Skyrizi 150 MG/ML penml
Ended Awarded Last action
- Contract number
- SPE2DR26F9NP4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $55,341
Award facts
- Contract value 100% obligated
- $55,340.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded Amerisourcebergen Drug Corp a $55,340.88 delivery order on January 29, 2026, for SKYRIZI 150 mg/mL pen injections, with a completion date of January 30, 2026. The award represents a firm fixed-price contract with no set-aside designation, indicating competitive procurement. The product will be delivered to the Conshohocken, Pennsylvania location. This delivery order is issued under Amerisourcebergen's parent company, Cencora, Inc. (doing business as Amerisourcebergen), which maintains a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031.
Cencora, Inc. serves as a critical pharmaceutical distributor and healthcare solutions provider supporting federal medical procurement, particularly for military and veteran healthcare systems. SKYRIZI is a biologic immunosuppressant used in the treatment of inflammatory dermatological conditions and is part of the company's comprehensive portfolio of pharmaceutical products supplied to government healthcare systems. The contract structure demonstrates Amerisourcebergen's established capability to fulfill federal medical supply requirements through the DLA Troop Support Medical prime vendor program, which enables efficient distribution of pharmaceutical products and medical supplies across military treatment facilities and related federal healthcare institutions worldwide.
Quick answers
Who was awarded contract SPE2DR26F9NP4?
SPE2DR26F9NP4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F9NP4 worth?
The government has obligated $55,341 on SPE2DR26F9NP4.
Is contract SPE2DR26F9NP4 an order under another contract?
Yes. SPE2DR26F9NP4 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9NP4 competed?
The extent of competition for SPE2DR26F9NP4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award